Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Pharmaceuticals Major
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | -0.26% | 165.19 | 0.7% | $1305.30m | |
| LLY | Eli Lilly & Co. | 0.57% | 331.78 | 1.1% | $1072.82m | |
| ABBV | AbbVie, Inc. | 0.94% | 143.33 | 1.9% | $877.03m | |
| PFE | Pfizer Inc. | -0.47% | 44.25 | 0.9% | $815.29m | |
| BMY | Bristol-Myers Squibb Co. | 0.34% | 71.45 | 1.0% | $767.68m | |
| MRK | Merck & Co., Inc. | 0.01% | 88.40 | 0.7% | $706.05m | |
| AZN | AstraZeneca Plc | -0.54% | 56.73 | 1.0% | $402.73m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | -0.11% | 201.02 | 8.2% | $225.00m | |
| GSK | GSK Plc | -1.01% | 30.40 | 0.3% | $210.45m | |
| NVS | Novartis AG | -1.11% | 77.36 | 0.2% | $209.93m | |
| IDXX | IDEXX Laboratories, Inc. | 0.44% | 350.12 | 3.9% | $189.64m | |
| GBT | Global Blood Therapeutics, Inc. | 0.00% | 68.49 | 5.4% | $183.92m | |
| HZNP | Horizon Therapeutics Plc | 1.35% | 67.05 | 5.4% | $182.38m | |
| NVO | Novo Nordisk A/S | 0.63% | 106.04 | 0.1% | $132.75m | |
| SRPT | Sarepta Therapeutics, Inc. | -0.76% | 110.62 | 12.4% | $132.70m |
Company Profile
Ampio Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in December 2008 and is headquartered in Englewood, CO.